You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
In connection with Lars Fruergaard Jørgensen being fired, the chairman of the main owner, Lars Rebien Sørensen, took the opportunity to take a seat as an observer on Novo Nordisk's board. I pointed out at the time that...
Previous chronicles
The thermometer reads 78 degrees of winter chill – but the forecast promises spring sun
From green shoots to record highs – the turnaround is here
Flerie continues to cherry-pick the best opportunities
AI braces for a crash – biotech waits for retail to return
The generalists about to jump on the bandwagon
Pfizer’s whining confirm it – Metsera is the perfect fit for Novo
All power to Sørensen – more turbulence ahead
Biotech shows increasing signs of life – is there more upside?
Big pharma ditches the UK – A stark warning
Is Nordic life science on sale?
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account